Study Finds ADHD Medications Effective for Symptoms but Limited in Improving Quality of Life
Comprehensive analysis highlights short-term benefits of stimulant drugs and atomoxetine while underscoring gaps in long-term research and non-drug treatments.
- A systematic review of 113 trials involving nearly 15,000 adults with ADHD found stimulants and atomoxetine effective in reducing core symptoms like inattention and hyperactivity over 12 weeks.
- Non-pharmacological treatments, including cognitive behavioral therapy and mindfulness, showed inconsistent results and were less effective according to patient self-reports than clinician evaluations.
- The study revealed that no treatments, including medications, significantly improved executive function or overall quality of life in adults with ADHD.
- Researchers emphasized the need for a multimodal approach combining medication and non-drug therapies to address both symptoms and broader life challenges faced by individuals with ADHD.
- Experts highlighted a critical lack of long-term data on the efficacy and safety of ADHD treatments, calling for more research to personalize interventions and address diverse patient needs.
EL PAÍS 
The Independent 
The Telegraph 
CNN 
Australian Broadcasting Corporation 
Evening Standard 